Health Care IT

October 21, 2016

Companies covered: athenahealth, Inc. (NASDAQ:ATHN), Medical Transcription Billing, Corp. (NASDAQ:MTBC), HealthEquity, Inc. (NASDAQ:HQY), Cerner Corporation (NASDAQ:CERN), Medidata Solutions, Inc. (NASDAQ:MDSO), Oracle Corporation (NYSE:ORCL), WebMD Health Corp (NASDAQ:WBMD), Inovalon Holdings Inc (NASDAQ:INOV), Microsoft Corporation (NASDAQ:MSFT), Alphabet Inc (NASDAQ:GOOG), Salesforce.com Inc (NYSE:CRM), Siemens AG (OTCMKTS:SIEGY), General Electric Company (NYSE:GE), Cotiviti Holdings Inc (NYSE:COTV), Aimmune Therapeutics Inc (NASDAQ:AIMT), Computer Task Group, Incorporated (NASDAQ:CTG), Actua Corporation (NASDAQ:ACTA), WNS (Holdings) Limited (NYSE:WNS), HealthStream, Inc. (NASDAQ:HSTM), HMS Holdings Corp (NASDAQ:HMSY), ExlService Holdings, Inc. (NASDAQ:EXLS), American Express Company (NYSE:AXP)

Buy ($175)

Medical Research, Diagnostic Substances & Life Science Tools

October 21, 2016

Companies covered: Mauna Kea Technologies (OTCMKTS:MKEAY), BioTime, Inc. (AMEX:BTX), PhaseRx, Inc. (NASDAQ:PZRX), Dynatronics Corporation (NASDAQ:DYNT), Anavex Life Sciences Corp. (NASDAQ:AVXL), Cellectis S.A. (NASDAQ:CLLS), Digipath, Inc. (OTCMKTS:DIGP), EDAP TMS S.A. (NASDAQ:EDAP), BioSig Technologies Inc (OTCMKTS:BSGM), DelMar Pharmaceuticals Inc (NASDAQ:DMPI), Pressure BioSciences Inc. (OTCMKTS:PBIO), Clearside Biomedical Inc (NASDAQ:CLSD), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Aimmune Therapeutics Inc (NASDAQ:AIMT), DBV Technologies S.A. (NASDAQ:DBVT), Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Tobira Therapeutics Inc. (NASDAQ:TBRA), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), United Therapeutics Corporation (NASDAQ:UTHR), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), Allergan, Inc. (NYSE:AGN), Edwards Lifesciences Corporation (NYSE:EW), Medtronic, Inc. (NYSE:MDT), ABIOMED, Inc. (NASDAQ:ABMD), Wright Medical Group, Inc. (NASDAQ:WMGI), DexCom, Inc. (NASDAQ:DXCM), Insulet Corporation (NASDAQ:PODD), ResMed Inc. (NYSE:RMD)

Buy ($175)

Biotechnology and Pharmaceuticals

August 12, 2016

Companies covered: Bayer AG (ADR) (OTCMKTS:BAYRY), Axovant Sciences Ltd (NYSE:AXON), AveXis Inc (NASDAQ:AVXS), uniQure N.V. (NASDAQ:QURE), Spark Therapeutics, Inc. (NASDAQ:ONCE), Ophthotech Corporation (NASDAQ:OPHT), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Novartis AG (NYSE:NVS), The Medicines Company (NASDAQ:MDCO), GlaxoSmithKline PLC (NYSE:GSK), Astrazeneca PLC (NYSE:AZN), Novo Nordisk A/S (NYSE:NVO), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Sanofi (NYSE:SNY), Pfizer, Inc. (NYSE:PFE), Regenxbio Inc (NASDAQ:RGNX), Endo International plc (NASDAQ:ENDP), Cipher Pharmaceuticals Inc. (NASDAQ:CPHR), NUVO PHARMACEUTICA COM NPV (OTCMKTS:NRIFF), Horizon Pharma plc (NASDAQ:HZNP), Retrophin, Inc. (NASDAQ:RTRX), Cempra, Inc. (NASDAQ:CEMP), Omeros Corporation (NASDAQ:OMER), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), T2 Biosystems, Inc. (NASDAQ:TTOO), Kadmon Holdings Inc (NYSE:KDMN), American International Group, Inc. (NYSE:AIG), Amgen Inc. (NASDAQ:AMGN), Biogen Idec Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Sophiris Bio, Inc. (NASDAQ:SPHS), Mateon Therapeutics, Inc. (NASDAQ:MATN), PharmaCyte Biotech, Inc. (OTCMKTS:PMCB), Biostage, Inc. (NASDAQ:BSTG), Ignyta, Inc. (NASDAQ:RXDX), Asterias Biotherapeutics, Inc. (AMEX:AST), Hemispherx Biopharma, Inc. (NYSEMKT:HEB), pSivida Corp. (NASDAQ:PSDV), Aytu BioScience, Inc. (OTCMKTS:AYTU), Apricus Biosciences, Inc (NASDAQ:APRI)

Buy ($175)

Medical Devices

July 29, 2016

Companies covered: Mazor Robotics Ltd. (NASDAQ:MZOR), Nuvectra Corporation (NASDAQ:NVTR), Miramar Labs, Inc. (OTCMKTS:MRLB), Myriad Genetics, Inc. (NASDAQ:MYGN), TESARO, Inc. (NASDAQ:TSRO), Thermo Fisher Scientific Inc (NYSE:TMO), Waters Corporation (NYSE:WAT), CEPHEID (NASDAQ:CPHD), Boston Scientific Corporation (NYSE:BSX), Baxter International Inc. (NYSE:BAX), Medtronic, Inc. (NYSE:MDT), Intuitive Surgical, Inc. (NASDAQ:ISRG), Covidien Ltd. (NYSE:COV), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), C.R. Bard, Inc. (NYSE:BCR), Illumina, Inc. (NASDAQ:ILMN), Cerner Corporation (NASDAQ:CERN), Edwards Lifesciences Corporation (NYSE:EW), St. Jude Medical, Inc. (NYSE:STJ), Hill-Rom Holdings Inc (NYSE:HRC), Cooper Companies, Inc. (The) (NYSE:COO), Teleflex Incorporated (NYSE:TFX)

Buy ($175)

Biotechnology and Pharmaceuticals

January 15, 2016

Companies covered: Gilead Sciences, Inc. (NASDAQ:GILD), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), Cempra, Inc. (NASDAQ:CEMP), Achaogen, Inc. (NASDAQ:AKAO), Wave Life Sciences Ltd (NASDAQ:WVE), Intrexon Corporation (NYSE:XON), Johnson & Johnson (NYSE:JNJ), Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Fibrocell Science Inc (NASDAQ:FCSC), Synthetic Biologics, Inc (NYSEMKT:SYN), Juno Therapeutics, Inc. (NASDAQ:JUNO), Kite Pharma, Inc. (NASDAQ:KITE), Lightlake Therapeutics (OTCMKTS:LLTP), Cynapsus Therapeutics Inc (NASDAQ:CYNA), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Bio-Path Holdings, Inc. (NASDAQ:BPTH)

Buy ($175)

Pin It on Pinterest